"We have this industry standard for how the profession has existed. Now, there's this sort of complete interruption with the tech that we're seeing be deployed."
"With both drugs and AI tools, there are inherent risks and there are inherent benefits. There are some uses that present major benefits and minimal risk, and some that produce fewer benefits and larger risks."
The legal industry is transitioning from AI experimentation to implementation, raising questions about malpractice for those not using AI. Judge Jesse Furman indicated that not utilizing AI could lead to legal risks, such as fee disputes. Joe Stephens emphasized the need for law students to adapt to new technologies. The panel discussed the evolving definition of competence, the risks associated with AI, and drew parallels to the pharmaceutical industry, highlighting the balance of benefits and risks in both fields.
Read at Above the Law
Unable to calculate read time
Collection
[
|
...
]